Heat Shock Factor 1 Inhibition Sensitizes Pancreatic Cancer to Gemcitabine via the Suppression of Cancer Stem Cell-Like Properties

Panc-1 and MiaPaCa-2 cells treated chronically with gemcitabine displayed increased transcription and expression of CSC-associated markers.